Trial record 1 of 1 for:
NCT05422482
A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients With MPS Ⅱ
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05422482 |
|
Recruitment Status :
Recruiting
First Posted : June 16, 2022
Last Update Posted : April 12, 2024
|
Sponsor:
GC Biopharma Corp
Information provided by (Responsible Party):
GC Biopharma Corp
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2026 |
| Estimated Study Completion Date : | June 2026 |